KNSA — KINIKSA PHARMACEUTICALS INTL

Ownership history in Point72 (DIFC) Ltd  ·  2 quarters on record

This page tracks every 13F SEC filing in which Point72 (DIFC) Ltd reported a position in KINIKSA PHARMACEUTICALS INTL (KNSA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q2 ADDED 2,600 +1,677 +181.7% 0.00% $72K $27.67
2025 Q1 INITIATED 923 — — 0.00% $20K $22.21
% of Fund (quarterly)    KNSA price (monthly, adj. close)

Other funds also holding KNSA

As of 2025 Q4 — sorted by position size

TANG CAPITAL MANAGEMENT LLC 3Y 7Y 4.6% Fairmount Funds Management LLC 3Y 4.14% Parkman Healthcare Partners LLC 3Y 2.61% Rubric Capital Management LP 3Y 7Y 1.64% ESSEX INVESTMENT MANAGEMENT CO LLC 3Y 7Y 1.58% RICE HALL JAMES & ASSOCIATES, LLC 3Y 7Y 1.35% Soleus Capital Management, L.P. 3Y 0.89% Logos Global Management LP 3Y 0.87% BAKER BROS. ADVISORS LP 3Y 7Y 0.68% GLOBEFLEX CAPITAL L P 3Y 7Y 0.59%
← Back to Point72 (DIFC) Ltd Holdings